Company: TDBCP
Filing Date: 2025-03-04
Form Type: 424B3
Source: 0001140361-25-006811
Chunk: 7

Company: TORONTO DOMINION BANK
Filing Date: 2025-03-04
Form: 424B3
Chunk 7
---
 accounting, auditing, and financial reporting standards and requirements applicable to foreign companies in foreign countries may differ from those applicable to U.S. reporting companies. |

PS-8 Unless otherwise set forth in the applicable term sheet, we and the agents do not control any Underlying Fund or any company whose securities are included in or held by any Market Measure and have not verified any disclosure made by any Market Measure Publisher or any of those companies.We, the agents and/or our or their respective affiliates currently, or in the future, may engage in business with the Market Measure Publishers or any company whose securities are included in or held by a Market Measure, and we, the agents, and/or our or their respective affiliates may from time to time own securities of those companies. However, none of us, the agents, or any of our or their respective affiliates has the ability to control the actions of any of these companies or has undertaken any independent review of, or made any due diligence inquiry with respect to, any of these companies, unless (and only to the extent that) the securities of us, the agents, and/or our or their respective affiliates are represented or held by that Market Measure. In addition, unless otherwise set forth in the applicable term sheet, none of us, the agents, and/or any of our or their respective affiliates is responsible for the calculation of any Index, Underlying Fund or Underlying Index. Unless otherwise specified therein, any information in the applicable term sheet regarding the Market Measure is derived from publicly available information. You should make your own investigation into the Market Measure. Unless otherwise set forth in the applicable term sheet, none of the Market Measure Publishers, their affiliates, or any companies included in the Market Measure will be involved in any offering of ARNs or will have any obligation of any sort with respect to ARNs. As a result, none of those companies will have any obligation to take your interests as holders of ARNs into consideration for any reason, including taking any corporate actions that might adversely affect the value of the securities represented by the Market Measure or the market value of, and any amount payable on, ARNs. Additional Risks Related to Underlying Funds There are liquidity and management risks associated with an Underlying Fund.Although shares of any Underlying Fund to which your ARNs are linked will be listed for trading on a securities exchange and a number of similar products have been traded on various exchanges for varying periods of time, there is no assurance that an active trading market will continue for the shares of that Underlying Fund or that there